Bruker Launches New timsTOF-based MALDI PharmaPulse® Solution for Label-free HTS in Drug Discovery


timsTOF MALDI PharmaPulse® (timsTOF MPP) for Unprecedented High-Throughput Screening (HTS) information content and throughput • Innovative timsTOF platform combined with extreme MALDI PharmaPulse speed and robustness for unbiased, deep HTS and uHTS (ultra-high-throughput screening) • Trapped Ion Mobility Spectrometry (TIMS): Exploiting ion mobility separation as a new dimension in HTS combined with high resolution QTOF-MS • Enabling new insights into molecular interactions in label-free HTS and uHTS in drug discovery • Accelerating drug molecule design by ultra-fast, information-rich CCS-enabled synthesis screening in support of HTE chemistry.

Read more about this news here.

Related articles

Recent articles